An array of signaling pathways that mediate these patterns have been proposed (see review [60]); however, the precise mechanism by which the reduced uptake of extracellular fatty acids by SR-B2/CD36 influences cancer cell biology remains a mystery. The gene discussed is CD36; the disease is cancer.